
Kevin Weil, who led OpenAI for Science, has launched Warp Sciences with $215M led by Lightspeed, valuing it at $865M, Bloomberg reported. It is building an automated lab in the US for a drug development step that pharma companies have long outsourced to Chinese firms such as WuXi AppTec. Kevin…
No discussion yet. Be the first to share your thoughts!